AFA October 2014

Page 1

AF A

Today

Issue 12, Autumn 2014 Complimentary to all AF Association subscribers

Providing information, support and access to established, new or innovative treatments for atrial fibrillation

NICE puts patients at the heart of decision-making and choice In June 2014, NICE updated their 2006 recommendations for the treatment and management of AF. To reinforce their new guideline, they have placed the patient at the forefront of treatment provision, reinforced by resources for patients and clinicians. One of NICE’s support resources is available in the form of a Patient Decision Aid (PDA) about anticoagulant treatments. Not all anticoagulant options for AF may be suitable or possible for everyone, depending on your particular health conditions and lifestyle circumstances, and each option also has advantages and disadvantages people feel differently about. The PDA provides balanced information about these for you to mull over before deciding on whether to take an anticoagulant, and which one you want to use. It is designed for you to work through with the healthcare professional who is helping you make this decision. As well as the PDA, NICE and a group of other health care organisations and patient group representatives have published a Consensus Statement on non-vitamin K antagonist oral anticoagulants (also known as novel anticoagulants or NOACs). It describes some of the barriers to the use of NOACs for reducing AF-related stroke risk, and how these barriers might be overcome locally to facilitate their appropriate use. The actual clinical guideline (NICE CG180), and the abovementioned resources, are available to view on our website.

“I hope that tools such as the AF Association Care AF package and NICE Patient Decision Aid will support others in seeking treatments to help them early on in their care journey, not when it is too late.”

Working with your clinician Your first consultation with a cardiologist or electrophysiologist is key to your way forward. The specialist will be able to refer to data gathered from tests and this will inform their way forward. Hard data from diagnostic tests are, however, only half the story and you will need to fill in the gaps and be prepared with questions for your specialist about treatment options for your AF. The condition is very complex and patient-specific, and as well as this, lifestyles vary between individuals, and it is vital that decisions about management of your AF fit in with each other. Questions you may want to ask can be found on page ten of NICE’s Consensus report.

“These new guidelines have been long in the planning stage and we are now fully committed to making sure they are disseminated and followed, in an effort to save as many lives as possible from preventable AF-related strokes. Thanks to tools released by AF Association, [patients] will know how and where to call on support from those working in the field of heart rhythm care.” Professor Richard Schilling, Consultant Cardiologist & EP

If you have been diagnosed with AF and are seeking more information to prepare you for your AF treatment journey, do visit the ‘Care AF’ website www.careaf.org for advice on risk of AF-related stroke, healthy living, patient stories, and more.

INSIDE

Patient support – Pg 4

 Glyn Davies MP – Pg 5

 Inspiration – Pg 9

Eileen Porter, patient representative

 AF Association PO Box 6219 Shipston-on-Stour CV37 1NL +44 (0) 1789 867 502 @ info@afa.org.uk www.afa.org.uk Registered Charity No: 1122442 AF-A ©2014


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.